Society of Interventional Radiology Quality Improvement Standards for Percutaneous Transcatheter Embolization

Abstract

SIR DISCLAIMERSIR develops standards to provide educational resources to practicing clinicians to promote high-quality outcomes and patient safety in vascular and interventional radiology. The standards are not fixed rules, nor are they the sole determinant of treatment choice, and they are not intended to establish a legal standard of care. The use of the standards is voluntary, and a deviation from the recommendations should not automatically be interpreted as the delivery of care that is substandard. The standards are not intended to supplant professional judgment, and a physician may deviate from these guidelines, as necessitated by individual patients, practice setting, or available resources. Other sources of information may be used in conjunction with these principles to produce a process leading to high-quality medical care. The ultimate judgment regarding the conduct of any specific procedure or course of management must be made by the physician, who should consider all circumstances relevant to the individual clinical situation. These standards are provided "AS IS," and SIR does not warrant the accuracy, reliability, completeness, or timeliness of the standards. SIR is not responsible for any actions taken in reliance on these standards, including, but not limited to, any treatment decisions made by any health care provider reading these guidelines, and SIR assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of these guidelines or for any errors or omissions.

Drug-Eluting Bead Bronchial Arterial Chemoembolization With and Without Microwave Ablation for the Treatment of Advanced and Standard Treatment-Refractory/Ineligible Non-Small Cell Lung Cancer: A Comparative Study

“…MWA- or DEB-BACE-related complications were evaluated according to criteria from the SIR ( 21 , 23 ). Enhanced CT was routinely performed every 3 months.…”

Standard treatment-refractory/ineligible small cell lung cancer treated with drug-eluting beads bronchial arterial chemoembolization: a retrospective cohort study

“…DEB-BACE-related AEs were analyzed as per the criteria from the Society of Interventional Radiology (22). AEs of anlotinib and immunotherapy were graded on the basis of the National Cancer Institute Common Terminology Criteria for Adverse Events, version 5.0 (23).…”

Material characterization of GPX®: A versatile in situ solidifying embolic platform technology

“…Endovascular embolization is a minimally invasive procedure during which transcatheter delivery of embolic devices or agents, guided by real-time imaging, block blood flow to targeted tissues with therapeutic intent ( Hu et al, 2019 ). Medical conditions treatable by endovascular embolization are diverse and continue to expand ( Dariushnia et al, 2021 ). Broad categories include occlusion of vascular malformations or other vascular and lymphatic abnormalities ( Wu et al, 2019 ; Vollherbst et al, 2022 ), control of acute bleeding due to disease, trauma, or surgery ( Loffroy and Guiu, 2009 ; Jeske et al, 2010 ; Lopera, 2010 ), and devascularization of benign and malignant tumors ( Ginat et al, 2009 ; Lazzaro et al, 2011 ; Bester et al, 2014 ; Talenfeld et al, 2014 ).…”